ArticleInternational journal of clinical pharmacy2021

Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database.

Mingxing Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.